RenovoRx, Inc. RNXT
1.29 USD +0.03 (+2.38%)
At closeNov 3, 2026, 4:01 PM EST
1.29 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
1.24 Day range 1.33
0.701 52-week range 2.59
- YTD
- +53.57%
- 1 year
- +18.35%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 5.50 +326.4% upside
Now 1.29
- Target (low)
- 3.50
- Target (mean)
- 5.50
- Target (high)
- 9.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.12 | -0.12 – -0.12 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -0.12 | -0.12 – -0.12 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -0.40 | -0.40 – -0.40 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next year | -0.46 | -0.46 – -0.46 | -0.40 | -15.0% | 333.33K | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 10, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Sep 12, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jun 17, 2024 | Ascendiant Capital | Initiated | — | Buy |
| Feb 2, 2024 | Alliance Global Partners | Initiated | — | Buy |
| Nov 15, 2023 | Maxim Group | Downgrade | Buy | Hold |
| Aug 18, 2023 | Roth MKM | Maintained | Buy | Buy |
| Nov 1, 2021 | Roth Capital | Initiated | — | Buy |
| Oct 6, 2021 | Maxim Group | Initiated | — | Buy |